RTTNews | Aug 12, 2020 08:07AM EDT

08:07 Wednesday, August 12, 2020 (RTTNews) - Vaccibody And Nektar Therapeutics Announce First Patient Dosed In Phase 1/2a Study Arm Evaluating VB10.NEO With NKTR-214

For comments and feedback: contact editorial@rttnews.comCopyright(c) 2020 RTTNews.com. All Rights Reserved